0001127602-13-013766.txt : 20130411 0001127602-13-013766.hdr.sgml : 20130411 20130411181740 ACCESSION NUMBER: 0001127602-13-013766 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130411 FILED AS OF DATE: 20130411 DATE AS OF CHANGE: 20130411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DWEK RAYMOND CENTRAL INDEX KEY: 0001231617 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 13757116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-04-11 0001082554 UNITED THERAPEUTICS Corp UTHR 0001231617 DWEK RAYMOND C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 1 Common Stock 2013-04-11 2013-04-11 4 M 0 6000 22.565 A 6000 D Common Stock 2013-04-11 2013-04-11 4 M 0 3000 27.70 A 9000 D Common Stock 2013-04-11 2013-04-11 4 S 0 9000 61.35 D 0 D Stock Options 22.565 2013-04-11 2013-04-11 4 M 0 6000 0 D 2005-06-25 2015-04-01 Common Stock 6000 0 D Stock Options 27.70 2013-04-11 2013-04-11 4 M 0 3000 0 D 2007-06-26 2016-06-26 Common Stock 3000 23000 D This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009. This transaction was executed in multiple trades at prices ranging from $61.35 to $61.36. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ John S. Hess, Jr. under Power of Attorney 2013-04-11